BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33139233)

  • 1. Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center.
    Tiu A; Jorge V; Moussa P; Djibo DA; Gupta S; Alpdogan O; Dourado C
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):205-215. PubMed ID: 33139233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.
    Khullar K; Plascak JJ; Drachtman R; Cole PD; Parikh RR
    Cancer Med; 2021 Feb; 10(4):1327-1334. PubMed ID: 33503323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
    Griffiths R; Gleeson M; Knopf K; Danese M
    BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.
    MacDougall K; Day S; Hall S; Zhao D; Pandey M; Ibrahimi S; Khawandanah M; Chakrabarty JH; Asch A; Nipp R; Al-Juhaishi T
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):379-384. PubMed ID: 36813625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
    Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY
    Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma.
    Ulu BU; Yiğenoğlu TN; Başcı S; Bakırtaş M; Şahin D; Darçın T; Yaman S; Bozan E; Seçilmiş S; Candır BA; Yıldız J; İskender D; Baysal NA; Çakar MK; Dal MS; Altuntaş F
    Leuk Res; 2021 Nov; 110():106700. PubMed ID: 34481125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients.
    Luo H; Yi P; Wang W; Li K; Meng L; Li J; Zeng W; Tang M
    Med Sci Monit; 2019 Nov; 25():8671-8682. PubMed ID: 31734687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].
    Song JL; Wei XL; Zhang YK; Hao XX; Huang WM; Wei Q; Wei YQ; Feng R
    Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):739-744. PubMed ID: 30369184
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
    Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
    Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
    BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma.
    Shah BK; Bista A; Shafii B
    Leuk Lymphoma; 2015 Apr; 56(4):983-6. PubMed ID: 24991720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.
    Chen Q; Ayer T; Nastoupil LJ; Koff JL; Staton AD; Chhatwal J; Flowers CR
    Leuk Lymphoma; 2016; 57(4):842-51. PubMed ID: 26415108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
    Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
    Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.